Biomea Fusion, Inc. Proceeds from Common Stock Issued
Biomea Fusion, Inc. (BMEA) reported Proceeds from Common Stock Issued of $4.91 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-05
- Biomea Fusion, Inc. proceeds from issuance of common stock for the quarter ending 2025-12-31 was -$124.00K.
- Biomea Fusion, Inc. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $0.00.
- Biomea Fusion, Inc. proceeds from issuance of common stock for the quarter ending 2025-06-30 was $1.77M.
- Biomea Fusion, Inc. proceeds from issuance of common stock for the quarter ending 2025-03-31 was $3.26M.
- Biomea Fusion, Inc. proceeds from issuance of common stock for fiscal 2025 was $4.91M.
- Biomea Fusion, Inc. proceeds from issuance of common stock for fiscal 2023 was $161.80M.
- Biomea Fusion, Inc. proceeds from issuance of common stock for fiscal 2020 was $10.19M, a 607.78% increase from fiscal 2019.
- Biomea Fusion, Inc. proceeds from issuance of common stock for fiscal 2019 was $1.44M.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$124.00K derived: sum of 2 quarters · filed 2026-03-24 | $1.65M derived: sum of 3 quarters · filed 2026-08-05 | $4.91M 10-K · filed 2026-03-24 | ||
| 2025-10-31 | $23.10M 10-K · filed 2026-03-24 | |||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.77M derived: sum of 2 quarters · filed 2026-08-05 | $5.03M 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | $37.20M 10-Q · filed 2026-08-05 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.03M 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | $3.26M 10-Q · filed 2026-05-11 | |||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-05 | |||||
| 2023-12-31 | $161.80M 10-K · filed 2025-03-31 | |||||
| 2023-04-30 | $161.80M 10-Q · filed 2026-08-05 | |||||
| 2023-04-03 | $161.80M 10-K · filed 2025-03-31 | |||||
| 2020-12-31 | $650.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $582.00K derived: sum of 2 quarters · filed 2023-03-28 | $10.14M derived: sum of 3 quarters · filed 2023-03-28 | $10.19M 10-K · filed 2023-03-28 | ||
| 2020-09-30 | -$68.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $9.49M derived: sum of 2 quarters · filed 2021-11-03 | $9.54M 10-Q · filed 2021-11-03 | |||
| 2020-06-30 | $9.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $9.61M 10-Q · filed 2021-08-11 | ||||
| 2020-03-31 | $50.00K 10-Q · filed 2021-05-27 | |||||
| 2019-12-31 | $1.44M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |